OUR PEOPLE
Emily Mrig, PhD
Assistant Professor
School of Pharmacy
490 Illinois Street, #32N
San Francisco, CA 94158
Image
Education and Training
Yale University,New Haven, CT, Post-Doctoral Fellowship - Health Policy & Management
University of Colorado,Denver, CO, MA - Medical Anthropology
University of Colorado,Denver, CO, PhD - Health & Behavioral Sciences
Scripps College,Claremont, CA, BA - History/ Hispanic Studies
Awards and Honors
Fredrick Hard Outstanding Thesis Award, Scripps College, 2004
American Dissertation Fellowship Prize, American Association of University Women (AAUW), 2018-2019
Outstanding Doctoral Student Award, Health & Behavioral Sciences Department, University of Colorado, Denver, 2019
Outstanding Doctoral Student Award, College of Liberal Arts & Sciences, University of Colorado, Denver, 2019
NIH Health Disparities Research Institute Scholar, National Institute on Minority Health and Health Disparities (NIMHD), 2021
Population Health & Health Equity Scholars Award, University of California, San Francisco, 2023-2024
NIH Career Development Award (K01), National Human Genome Research Institute (NHGRI), 2024-2029
NIH LRP Award Recipient, National Institute on Minority Health and Health Disparities (NIMHD), 2025-2027
UCSF Emerging Scholar Award, Institute for Health Policy Studies (IHPS), 2026
Overview
Emily Hammad Mrig, PhD, MA, is an Assistant Professor in the Department of Clinical Pharmacy and at the Center for Translational and Policy Research on Precision Medicine (TRANSPERS) at the University of California, San Francisco. She holds a PhD in Health and Behavioral Sciences from the University of Colorado Denver and completed a postdoctoral fellowship in Health Policy and Management at Yale University.
Her research investigates disparities in healthcare access, with a focus on precision medicine, cancer, and undiagnosed/rare conditions. Dr. Mrig is the recipient of an NIH-NHGRI K01 Career Development Award examining payment pathways for molecular diagnostics and serves as Co-Investigator on a Department of Defense study aimed at improving the delivery of germline testing in Veterans with advanced prostate cancer, and an NHGRI R01 project focused on evidence-based and efficient precision medicine implementation.
Her current work employs innovative mixed-methods approaches, including AI-based techniques alongside traditional analyses of electronic health records, as well as patient narrative elicitation and multistakeholder engagement, to identify cost barriers to molecular diagnostics and targeted cancer therapies and to generate evidence supporting the equitable adoption of precision medicine technologies. She has published in high-impact journals such as Genetics in Medicine and the Journal of Health Policy, Politics & Law, and was recognized as a UCSF Population Health and Health Equity Scholar and recipient of the 2026 UCSF Emerging Scholar Award.
Her research investigates disparities in healthcare access, with a focus on precision medicine, cancer, and undiagnosed/rare conditions. Dr. Mrig is the recipient of an NIH-NHGRI K01 Career Development Award examining payment pathways for molecular diagnostics and serves as Co-Investigator on a Department of Defense study aimed at improving the delivery of germline testing in Veterans with advanced prostate cancer, and an NHGRI R01 project focused on evidence-based and efficient precision medicine implementation.
Her current work employs innovative mixed-methods approaches, including AI-based techniques alongside traditional analyses of electronic health records, as well as patient narrative elicitation and multistakeholder engagement, to identify cost barriers to molecular diagnostics and targeted cancer therapies and to generate evidence supporting the equitable adoption of precision medicine technologies. She has published in high-impact journals such as Genetics in Medicine and the Journal of Health Policy, Politics & Law, and was recognized as a UCSF Population Health and Health Equity Scholar and recipient of the 2026 UCSF Emerging Scholar Award.